BACKGROUND: Sexual minorities have documented elevated risk factors that can lead to inflammation and poor immune functioning. PURPOSE: This study aims to investigate disparities in C-reactive protein (CRP) and Epstein-Barr virus (EBV) by gender and sexual orientation. METHODS: We used the National Longitudinal Study of Adolescent Health to examine disparities in CRP (N = 11,462) and EBV (N = 11,812). RESULTS: Among heterosexuals, women had higher levels of CRP and EBV than men. However, sexual minority men had higher levels of CRP and EBV than heterosexual men and sexual minority women. Lesbians had lower levels of CRP than heterosexual women. CONCLUSIONS: Gender differences in CRP and EBV found between men and women who identify as 100 % heterosexual were reversed among sexual minorities and not explained by known risk factors (e.g., victimization, alcohol and tobacco use, and body mass index). More nuanced approaches to addressing gender differences in sexual orientation health disparities that include measures of gender nonconformity and minority stress are needed.
BACKGROUND: Sexual minorities have documented elevated risk factors that can lead to inflammation and poor immune functioning. PURPOSE: This study aims to investigate disparities in C-reactive protein (CRP) and Epstein-Barr virus (EBV) by gender and sexual orientation. METHODS: We used the National Longitudinal Study of Adolescent Health to examine disparities in CRP (N = 11,462) and EBV (N = 11,812). RESULTS: Among heterosexuals, women had higher levels of CRP and EBV than men. However, sexual minority men had higher levels of CRP and EBV than heterosexual men and sexual minority women. Lesbians had lower levels of CRP than heterosexual women. CONCLUSIONS: Gender differences in CRP and EBV found between men and women who identify as 100 % heterosexual were reversed among sexual minorities and not explained by known risk factors (e.g., victimization, alcohol and tobacco use, and body mass index). More nuanced approaches to addressing gender differences in sexual orientation health disparities that include measures of gender nonconformity and minority stress are needed.
Authors: T W McDade; J F Stallings; A Angold; E J Costello; M Burleson; J T Cacioppo; R Glaser; C M Worthman Journal: Psychosom Med Date: 2000 Jul-Aug Impact factor: 4.312
Authors: Mark L Hatzenbuehler; Katie A McLaughlin; Katherine M Keyes; Deborah S Hasin Journal: Am J Public Health Date: 2010-01-14 Impact factor: 9.308
Authors: Natalie Slopen; Laura D Kubzansky; Katie A McLaughlin; Karestan C Koenen Journal: Psychoneuroendocrinology Date: 2012-06-21 Impact factor: 4.905
Authors: Vickie M Mays; Robert-Paul Juster; Timothy J Williamson; Teresa E Seeman; Susan D Cochran Journal: Psychosom Med Date: 2018 Jul/Aug Impact factor: 4.312
Authors: S Bryn Austin; Margaret Rosario; Katie A McLaughlin; Andrea L Roberts; Allegra R Gordon; Vishnudas Sarda; Stacey Missmer; Laura Anatale-Tardiff; Emily A Scherer Journal: Psychoneuroendocrinology Date: 2016-04-21 Impact factor: 4.905
Authors: Lisa M Christian; Steve W Cole; Thomas McDade; John E Pachankis; Ethan Morgan; Anna M Strahm; Claire M Kamp Dush Journal: Neurosci Biobehav Rev Date: 2021-06-05 Impact factor: 9.052